Dr. Kristopher Mark Paolino, MD

Dr. Paolino practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Paolino's NPI, 1205952280, was assigned on March 22, 2007. Dr. Paolino graduated from University at Buffalo School of Medicine in 2005. Dr. Paolino holds New York license 283839.

Dr. Paolino's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Paolino's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Paolino is also affiliated with Crouse Hospital. The medical group on file is Department of Medicine. Dmand AI also links Dr. Paolino to 1 more hospital, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Paolino practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Paolino's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Paolino is licensed in New York.

CMS data shows 310 Medicare services from Dr. Paolino across 7 procedure codes in 2024, for 196 Medicare patients. Medicare paid $26,964 for them.

CMS counts 196 Medicare patients who saw Dr. Paolino in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Paolino's median patient age at 58, with 51% women.

In 2024, Dr. Paolino wrote 250 Medicare Part D claims for 51 patients. 100% of them were for generic drugs. CMS names the drug for 152 of them, across 5 drugs with 11 or more claims each, at $3,744 in total drug cost. In 2023, CMS named 139 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Paolino for performance year 2024, reported as part of a group. Dr. Paolino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Paolino as offering telehealth.

Dmand AI links 37 papers to Dr. Paolino, published from 2012 to 2025. 2016 was the busiest year, with 4. The most frequent topics are Anti-Bacterial Agents, Antibodies, Viral and Vaccination. Dr. Paolino has published most often in J Infect Dis. Dr. Paolino's most frequent co-authors are James Edward Moon, MD, Kristin T. Mills, DO and Ruanne Vanessa Barnabas, MBCHB.

Dmand AI links Dr. Paolino to 8 clinical trials, 4 of them phase 1 studies. Conditions studied include COVID-19, Dengue and Severe Acute Respiratory Syndrome. U.S. Army Medical Research and Development Command sponsors the most, 3.

CMS Open Payments shows 13 general payments to Dr. Paolino from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 93% of the total. Dynavax Technologies Corporation paid the most, $3,323. It also lists 2 research payments totaling $4,149 from 2016 to 2017.

Dr. Paolino graduated from University at Buffalo School of Medicine in 2005.